EP1991294A1 — Medical device with orientation sensitive priming mechanism
Assigned to SHL Group AB · Expires 2008-11-19 · 17y expired
What this patent protects
The present invention relates to a device for a medical device, which medical device comprises a body (10, 12) , a container (24) containing medicament, the container further comprising an expelling passage, and delivery drive means (36) for expelling said medicament, wherein sai…
USPTO Abstract
The present invention relates to a device for a medical device, which medical device comprises a body (10, 12) , a container (24) containing medicament, the container further comprising an expelling passage, and delivery drive means (36) for expelling said medicament, wherein said device comprises mechanical priming drive means (57) and mechanical priming activation (40) means being arranged and designed such that said mechanical priming activation means is capable of permitting activation of said mechanical priming drive means only when the medical device is substantially vertical with the expelling passage into an specific direction.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.